Keytruda contains Pembrolizumab, 100mg/4mL, supplied as injection. Manufacturer: Merck & Co. (MSD). Therapeutic class: Immunotherapy PD-1.
Prescription-only medicine. Supplied against a named-patient prescription, or to holders of a valid drug import or wholesale licence in the destination country.
For indications, dosing and safety information, refer to the approved product label in the prescriber’s country.